Nurix Therapeutics, Inc.

NASDAQ:NRIX

19.83 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -143.948-180.36-117.194-43.242-21.699-9.428
Depreciation & Amortization 13.65410.8086.0822.182.3542.988
Deferred Income Tax 00000-0.354
Stock Based Compensation 33.67328.13115.84.3010.510.431
Change In Working Capital 20.121-19.0229.11336.40819.545-25.306
Accounts Receivables 06-6-11.346012.374
Inventory 006.77411.34600
Accounts Payables 1.6140.0851.5891.2340.302-0.519
Other Working Capital 18.507-25.1076.7535.17419.243-24.787
Other Non Cash Items -4.8650.6361.8340.273-0.109-0.006
Operating Cash Flow -81.365-159.807-84.365-0.080.601-31.675
Investing Activities:
Investments In Property Plant And Equipment -8.401-12.244-5.661-4.553-1.651-1.595
Acquisitions Net 0-39.442102.59249.851-10.1490.006
Purchases Of Investments -246.334-239.366-348.497-275.224-9.351-12.917
Sales Maturities Of Investments 323.036278.808245.90725.37319.554.5
Other Investing Activites 039.442-102.59-249.85110.1490.006
Investing Cash Flow 68.30127.198-108.251-254.4048.49839.994
Financing Activities:
Debt Repayment 000000
Common Stock Issued 3.21719.4150.157218.1470.1420.531
Common Stock Repurchased 0000-0.016-0.002
Dividends Paid 000000
Other Financing Activities 3.21797.7923.725120.8770.1260.529
Financing Cash Flow 3.217117.192153.882339.0240.1260.529
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -9.847-15.417-38.73484.549.2258.848
Cash At End Of Period 55.52865.37580.792119.52634.98625.761